{"id":31068,"date":"2020-03-16T07:51:58","date_gmt":"2020-03-16T07:51:58","guid":{"rendered":"http:\/\/biomedpharmajournal.org\/?page_id=31068"},"modified":"2026-01-09T07:40:30","modified_gmt":"2026-01-09T07:40:30","slug":"editors-guidelines","status":"publish","type":"page","link":"https:\/\/biomedpharmajournal.org\/staging\/editors-guidelines\/","title":{"rendered":"Editor’s Guidelines"},"content":{"rendered":"

Guidelines for Editors<\/b><\/p>\n

The Biomedical and Pharmacology Journal (BPJ) Editors has ultimate responsibility for deciding if a manuscript submitted to\u00a0the journal\u00a0should be published, and in doing so is guided by the journal\u2019s policies as determined by the\u00a0journal\u2019s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism. The Editor may consult with the Associate Editor and other members of the editorial team, as well as with reviewers, in making publication decisions.<\/p>\n

The editors will evaluate manuscripts for their intellectual content without regard to race, color, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or political philosophy of the author(s). They will not disclose any information about a manuscript under consideration to anyone other than the author(s), reviewers and potential reviewers, and in some instances the\u00a0journal\u2019s editorial board members, as appropriate. Additionally, the editors will make every effort to ensure the integrity of the blind review process by not revealing the identity of the author(s) of a manuscript to the reviewers of that manuscript, and vice versa.<\/p>\n

When evaluating a manuscript for publication, in addition to considering standard criteria pertaining to the rigor of the manuscript, the quality of its presentation, and its contribution to humanity\u2019s stock of knowledge, the editors will also seek evidence that ethical harms have been minimized in the conduct of the reported research. They will question whether the benefits outweigh the harms in the particular study\u2019s case. Since Biomedical and Pharmacology Journal (BPJ) welcomes the submission of manuscripts from any country, it is necessary to recognize that laws and regulations regarding research ethics and ethical approval vary worldwide. As such, the editors may need to seek clarification in this regard with the author(s) and request that they supply a letter from the relevant institutional ethics committee or board that approved the research.<\/p>\n

The editors will be guided by CORE\u2019s\u00a0Guidelines for Retracting Articles<\/a>\u00a0when considering retracting, issuing an expression of concern about, and issuing corrections pertaining to articles that have been published in Biomedical and Pharmacology Journal (BPJ). They are committed to working closely with research organizations and institutions in line with CORE\u2019s advice on\u00a0Cooperation between Research Institutions and Journals on Research Integrity Cases<\/a><\/p>\n<\/div><\/div><\/div>

\r\n\t